A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...

Medical experts in India are calling for urgent attention to Respiratory Syncytial Virus (RSV), a highly contagious but under-discussed cause of lower respiratory tract infections in infants ...

Amid the sultry summer months, a few signs of fall become apparent, such as the appearance of school supplies on stores ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...